Announcements

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of methods and technologies development. The paper list is as follows:

“Multiphysics Modeling of Low-Intensity Pulsed Ultrasound Induced Chemotherapeutic Drug Release from the Surface of Gold Nanoparticles”
by Tyler K. Hornsby, Farshad Moradi Kashkooli, Anshuman Jakhmola, Michael C. Kolios and Jahangir (Jahan) Tavakkoli
Cancers 2023, 15(2), 523; https://doi.org/10.3390/cancers15020523
Available online: https://www.mdpi.com/2072-6694/15/2/523

“Hybrid Quantum Neural Network for Drug Response Prediction”
by Asel Sagingalieva, Mohammad Kordzanganeh, Nurbolat Kenbayev, Daria Kosichkina, Tatiana Tomashuk and Alexey Melnikov
Cancers 2023, 15(10), 2705; https://doi.org/10.3390/cancers15102705
Available online: https://www.mdpi.com/2072-6694/15/10/2705

“New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy”
by Sara C. Freitas, Daniel Sanderson, Sofia Caspani, Ricardo Magalhães, Belén Cortés-Llanos, Andreia Granja, Salette Reis, João Horta Belo, José Azevedo, Maria Victoria Gómez-Gaviro et al.
Cancers 2023, 15(2), 383; https://doi.org/10.3390/cancers15020383
Available online: https://www.mdpi.com/2072-6694/15/2/383

“Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience”
by Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin and Florian Rosar
Cancers 2023, 15(5), 1376; https://doi.org/10.3390/cancers15051376
Available online: https://www.mdpi.com/2072-6694/15/5/1376

“Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction”
by Sebastian Gassenmaier, Verena Warm, Dominik Nickel, Elisabeth Weiland, Judith Herrmann, Haidara Almansour, Daniel Wessling and Saif Afat
Cancers 2023, 15(3), 578; https://doi.org/10.3390/cancers15030578
Available online: https://www.mdpi.com/2072-6694/15/3/578

“Micro-Ultrasound: Current Role in Prostate Cancer Diagnosis and Future Possibilities”
by Adriano Basso Dias and Sangeet Ghai
Cancers 2023, 15(4), 1280; https://doi.org/10.3390/cancers15041280
Available online: https://www.mdpi.com/2072-6694/15/4/1280

“CBCT-to-CT Translation Using Registration-Based Generative Adversarial Networks in Patients with Head and Neck Cancer”
by Chitchaya Suwanraksa, Jidapa Bridhikitti, Thiansin Liamsuwan and Sitthichok Chaichulee
Cancers 2023, 15(7), 2017; https://doi.org/10.3390/cancers15072017
Available online: https://www.mdpi.com/2072-6694/15/7/2017

“Henry Gas Solubility Optimization Algorithm based Feature Extraction in Dermoscopic Images Analysis of Skin Cancer”
by Marwa Obayya, Adeeb Alhebri, Mashael Maashi, Ahmed S. Salama, Anwer Mustafa Hilal, Mohamed Ibrahim Alsaid, Azza Elneil Osman and Amani A. Alneil
Cancers 2023, 15(7), 2146; https://doi.org/10.3390/cancers15072146
Available online: https://www.mdpi.com/2072-6694/15/7/2146

“Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis”
by Anthony-Joe Nassour, Anika Jain, Nicholas Hui, George Siopis, James Symons and Henry Woo
Cancers 2023, 15(2), 506; https://doi.org/10.3390/cancers15020506
Available online: https://www.mdpi.com/2072-6694/15/2/506

“An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4”
by Lavanya Varier, S. Mohana Sundaram, Naisarg Gamit and Sudha Warrier
Cancers 2023, 15(4), 1275; https://doi.org/10.3390/cancers15041275
Available online: https://www.mdpi.com/2072-6694/15/4/1275

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Methods and Technologies Development”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. You can contact the Editorial Office (cancers@mdpi.com) for any questions you may have.

Cancers Editorial Office

MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the US, EU and China. 

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer causes, screening and diagnosis. The paper list is as follows:

“Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection”
by Dmitri Pchejetski, Ewan Hunter, Mehrnoush Dezfouli, Matthew Salter, Ryan Powell, Jayne Green, Tarun Naithani, Christina Koutsothanasi, Heba Alshaker, Jiten Jaipuria et al.
Cancers 2023, 15(3), 821; https://doi.org/10.3390/cancers15030821
Available online: https://www.mdpi.com/2072-6694/15/3/821

“DSCC_Net: Multi-Classification Deep Learning Models for Diagnosing of Skin Cancer Using Dermoscopic Images”
by Maryam Tahir, Ahmad Naeem, Hassaan Malik, Jawad Tanveer, Rizwan Ali Naqvi and Seung-Won Lee
Cancers 2023, 15(7), 2179; https://doi.org/10.3390/cancers15072179
Available online: https://www.mdpi.com/2072-6694/15/7/2179

“Is Pediatric Melanoma Really That Different from Adult Melanoma? A Multicenter Epidemiological, Clinical and Dermoscopic Study”
by Vincenzo De Giorgi, Elisabetta Magnaterra, Biancamaria Zuccaro, Serena Magi, Manfredi Magliulo, Matelda Medri, Laura Mazzoni, Federico Venturi, Flavia Silvestri, Gian Marco Tomassini et al.
Cancers 2023, 15(6), 1835; https://doi.org/10.3390/cancers15061835
Available online: https://www.mdpi.com/2072-6694/15/6/1835

“DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities”
by María Ovejero-Sánchez, Rogelio González-Sarmiento and Ana Belén Herrero
Cancers 2023, 15(2), 448; https://doi.org/10.3390/cancers15020448
Available online: https://www.mdpi.com/2072-6694/15/2/448

“Targeting the Molecular and Immunologic Features of Leiomyosarcoma”
by Brandon M. Cope, Raymond S. Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland and Elise F. Nassif
Cancers 2023, 15(7), 2099; https://doi.org/10.3390/cancers15072099
Available online: https://www.mdpi.com/2072-6694/15/7/2099

“Current and Emerging Techniques for Diagnosis and MRD Detection in AML: A Comprehensive Narrative Review”
by Alexandra Teixeira, Luís Carreira, Sara Abalde-Cela, Belém Sampaio-Marques, Anabela C. Areias, Paula Ludovico and Lorena Diéguez
Cancers 2023, 15(5), 1362; https://doi.org/10.3390/cancers15051362
Available online: https://www.mdpi.com/2072-6694/15/5/1362

“Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review”
by Michael G. Fadel, Mosab Ahmed, Gianluca Pellino, Shahnawaz Rasheed, Paris Tekkis, David Nicol, Christos Kontovounisios and Erik Mayer
Cancers 2023, 15(2), 455; https://doi.org/10.3390/cancers15020455
Available online: https://www.mdpi.com/2072-6694/15/2/455

“Outcomes of Robot-Assisted Surgery in Rectal Cancer Compared with Open and Laparoscopic Surgery”
by Elias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, Rajan Nikbakhsh, Gil Goncalves, Carlos Carvalho, Amjad Parvaiz, Yakup Kulu and Arianeb Mehrabi
Cancers 2023, 15(3), 839; https://doi.org/10.3390/cancers15030839
Available online: https://www.mdpi.com/2072-6694/15/3/839

“Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis”
by Faiza Gaba, Oleg Blyuss, Alex Tan, Daniel Munblit, Samuel Oxley, Khalid Khan, Rosa Legood and Ranjit Manchanda
Cancers 2023, 15(5), 1625; https://doi.org/10.3390/cancers15051625
Available online: https://www.mdpi.com/2072-6694/15/5/1625

“Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review”
by Federica Di Spirito, Giuseppe Pantaleo, Maria Pia Di Palo, Alessandra Amato, Annunziata Raimondo and Massimo Amato
Cancers 2023, 15(4), 1096; https://doi.org/10.3390/cancers15041096
Available online: https://www.mdpi.com/2072-6694/15/4/1096

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Survivorship and Quality of Life”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Systematic Review or Meta-Analysis in Cancer Research”. The paper list is as follows:

“The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review”
by Alessio Rizzo, Manuela Racca, Sara Dall’Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata and Giorgio Treglia
Cancers 2023, 15(2), 355; https://doi.org/10.3390/cancers15020355
Available online: https://www.mdpi.com/2072-6694/15/2/355

“A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma"
by Gabriela Villanueva, Martin Guscott, Paula Schaiquevich, Claudia Sampor, Ryan Combs, Nicolás Tentoni, Miriam Hwang, Jennifer Lowe and Scott Howard
Cancers 2023, 15(5), 1459; https://doi.org/10.3390/cancers15051459
Available online: https://www.mdpi.com/2072-6694/15/5/1459

“Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis”
by Ainsley Ryan Yan Bin Lee, Chun En Yau, Chen Ee Low, Jiaqi Li, Sara Moiz Tyebally, Weiqin Lin, Li-Ling Tan, Chia-Te Liao, Wei-Ting Chang, Matilda Xinwei Lee et al.
Cancers 2023, 15(2), 512; https://doi.org/10.3390/cancers15020512
Available online: https://www.mdpi.com/2072-6694/15/2/512

“Effectiveness of Colorectal Cancer (CRC) Screening on All-Cause and CRC-Specific Mortality Reduction: A Systematic Review and Meta-Analysis”
by Senshuang Zheng, Jelle J. A. Schrijvers, Marcel J. W. Greuter, Gürsah Kats-Ugurlu, Wenli Lu and Geertruida H. de Bock
Cancers 2023, 15(7), 1948; https://doi.org/10.3390/cancers15071948
Available online: https://www.mdpi.com/2072-6694/15/7/1948

“The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis”
by Brandon M. Cope, Raymond S. Traweek, Rossana Lazcano, Emily Z. Keung, Alexander J. Lazar, Christina L. Roland and Elise F. Nassif
Cancers 2023, 15(7), 2099; https://doi.org/10.3390/cancers15072099
Available online: https://www.mdpi.com/2072-6694/15/7/2099

“New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review”
by Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, Kalliopi Keramida, Andri Papakonstantinou, Carlo M. Cipolla, Dorothea Tsekoura, Katerina Naka, Ketti Mazzocco, Davide Mauri et al.
Cancers 2023, 15(13), 3290; https://doi.org/10.3390/cancers15133290
Available online: https://www.mdpi.com/2072-6694/15/13/3290

“Candidate Genes and Pathways in Cervical Cancer: A Systematic Review and Integrated Bioinformatic Analysis”
by Marjanu Hikmah Elias, Srijit Das and Nazefah Abdul Hamid
Cancers 2023, 15(3), 853; https://doi.org/10.3390/cancers15030853
Available online: https://www.mdpi.com/2072-6694/15/3/853

“Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis”
by Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani and Massimo Di Maio
Cancers 2023, 15(9), 2435; https://doi.org/10.3390/cancers15092435
Available online: https://www.mdpi.com/2072-6694/15/9/2435

“Occupational Exposures and Risks of Non-Hodgkin Lymphoma: A Meta-Analysis”
by Luiza Flavia Veiga Francisco, Rogério Nunes da Silva, Marco Antônio Oliveira, Martins Fideles dos Santos Neto, Iara Zapparoli Gonçalves, Márcia M. C. Marques and Henrique C. S. Silveira
Cancers 2023, 15(9), 2600; https://doi.org/10.3390/cancers15092600
Available online: https://www.mdpi.com/2072-6694/15/9/2600

“Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review”
by Athena Davri, Effrosyni Birbas, Theofilos Kanavos, Georgios Ntritsos, Nikolaos Giannakeas, Alexandros T. Tzallas and Anna Batistatou
Cancers 2023, 15(15), 3981; https://doi.org/10.3390/cancers15153981
Available online: https://www.mdpi.com/2072-6694/15/15/3981

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Causes, Screening and Diagnosis”. The Special Issues list is as follows:

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers via cancers@mdpi.com.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer drug development. The paper list is as follows:

“An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models”
by Donald Poirier, Jenny Roy, René Maltais, Cindy Weidmann and Étienne Audet-Walsh
Cancers 2023, 15(11), 3033; https://doi.org/10.3390/cancers15113033
Available online: https://www.mdpi.com/2072-6694/15/11/3033

“Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives”
by A K M Helal Morshed, Supti Paul, Arafat Hossain, Tuli Basak, Md. Sanower Hossain, Md. Mehedi Hasan, Md. Al Hasibuzzaman, Tanjim Ishraq Rahaman, Md. Abdur Rashid Mia, Pollob Shing et al.
Cancers 2023, 15(7), 2128; https://doi.org/10.3390/cancers15072128
Available online: https://www.mdpi.com/2072-6694/15/7/2128

“Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases”
by Christian Bailly and Xavier Thuru
Cancers 2023, 15(7), 2186; https://doi.org/10.3390/cancers15072186
Available online: https://www.mdpi.com/2072-6694/15/7/2186

“Seaweed-Derived Sulfated Polysaccharides; The New Age Chemopreventives: A Comprehensive Review”
by Prajna Paramita Bhuyan, Rabindra Nayak, Srimanta Patra, Hadi Sajid Abdulabbas, Mrutyunjay Jena and Biswajita Pradhan
Cancers 2023, 15(3), 715; https://doi.org/10.3390/cancers15030715
Available online: https://www.mdpi.com/2072-6694/15/3/715

“Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors”
by Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque, Blanca Xicoy, Pilar Giraldo, Raúl Pérez López, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Javier López Marín et al.
Cancers 2023, 15(4), 1045; https://doi.org/10.3390/cancers15041045
Available online: https://www.mdpi.com/2072-6694/15/4/1045

“Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment”
by Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune and Mitsunobu R. Kano
Cancers 2023, 15(3), 724; https://doi.org/10.3390/cancers15030724
Available online: https://www.mdpi.com/2072-6694/15/3/724

“Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers”
by Shoaib Shoaib, Farheen Badrealam Khan, Meshari A. Alsharif, M. Shaheer Malik, Saleh A. Ahmed, Yahya F. Jamous, Shahab Uddin, Ching Siang Tan, Chrismawan Ardianto, Saba Tufail et al.
Cancers 2023, 15(8), 2390; https://doi.org/10.3390/cancers15082390
Available online: https://www.mdpi.com/2072-6694/15/8/2390

“Naturally Isolated Sesquiterpene Lactone and Hydroxyanthraquinone Induce Apoptosis in Oral Squamous Cell Carcinoma Cell Line”
by Afshan Shams, Ayaz Ahmed, Ajmal Khan, Shariqa Khawaja, Najeeb Ur Rehman, Asma Saleem Qazi, Adnan Khan, Sami Bawazeer, Syed Abid Ali and Ahmed Al-Harrasi
Cancers 2023, 15(2), 557; https://doi.org/10.3390/cancers15020557
Available online: https://www.mdpi.com/2072-6694/15/2/557

“Multi-Fold Computational Analysis to Discover Novel Putative Inhibitors of Isethionate Sulfite-Lyase (Isla) from Bilophila wadsworthia: Combating Colorectal Cancer and Inflammatory Bowel Diseases”
by Muhammad Waqas, Sobia Ahsan Halim, Atta Ullah, Assim Alaa Mohammed Ali, Asaad Khalid, Ashraf N. Abdalla, Ajmal Khan and Ahmed Al-Harrasi
Cancers 2023, 15(3), 901; https://doi.org/10.3390/cancers15030901
Available online: https://www.mdpi.com/2072-6694/15/3/901

“Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells”
by Aysha Alneyadi, Zohra Nausheen Nizami, Hanan E. Aburawi, Soleiman Hisaindee, Muhammad Nawaz, Samir Attoub, Gaber Ramadan, Nehla Benhalilou, Mazoun Al Azzani, Yassine Elmahi et al.
Cancers 2023, 15(10), 2682; https://doi.org/10.3390/cancers15102682
Available online: https://www.mdpi.com/2072-6694/15/10/2682

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of transplant oncology. The paper list is as follows:

“New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy”
by Ezequiel Mauro, Joana Ferrer-Fàbrega, Tamara Sauri, Alexandre Soler, Amparo Cobo, Marta Burrel, Gemma Iserte and Alejandro Forner
Cancers 2023, 15(4), 1244; https://doi.org/10.3390/cancers15041244
Available online: https://www.mdpi.com/2072-6694/15/4/1244

“Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology”
by Karen Abboud, Godsfavour Umoru, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, Humaid O. Al-Shamsi, Milind Javle, Ashish Saharia, Ashton A. Connor, Sudha Kodali et al.
Cancers 2023, 15(5), 1433; https://doi.org/10.3390/cancers15051433
Available online: https://www.mdpi.com/2072-6694/15/5/1433

“Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues”
by Marianna Maspero, Carlo Sposito, Matteo Virdis, Davide Citterio, Filippo Pietrantonio, Sherrie Bhoori, Filiberto Belli and Vincenzo Mazzaferro
Cancers 2023, 15(2), 345; https://doi.org/10.3390/cancers15020345
Available online: https://www.mdpi.com/2072-6694/15/2/345

“Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience”
by Daniel Aliseda, Pablo Martí-Cruchaga, Gabriel Zozaya, Macarena Rodríguez-Fraile, José I. Bilbao, Alberto Benito-Boillos, Antonio Martínez De La Cuesta, Luis Lopez-Olaondo, Francisco Hidalgo, Mariano Ponz-Sarvisé et al.
Cancers 2023, 15(3), 733; https://doi.org/10.3390/cancers15030733
Available online: https://www.mdpi.com/2072-6694/15/3/733

“Machine Learning-Based Radiomic Features on Pre-Ablation MRI as Predictors of Pathologic Response in Patients with Hepatocellular Carcinoma Who Underwent Hepatic Transplant”
by Azadeh Tabari, Brian D’Amore, Meredith Cox, Sebastian Brito, Michael S. Gee, Eric Wehrenberg-Klee, Raul N. Uppot and Dania Daye
Cancers 2023, 15(7), 2058; https://doi.org/10.3390/cancers15072058
Available online: https://www.mdpi.com/2072-6694/15/7/2058

“Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period”
by Pierluca Piselli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Nicola Bossini, Paola Todeschini, Maurizio Iaria, Franco Citterio et al.
Cancers 2023, 15(4), 1347; https://doi.org/10.3390/cancers15041347
Available online: https://www.mdpi.com/2072-6694/15/4/1347

“Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant”
by Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Renata Glehn-Ponsirenas, Gennaro Selvaggi, Akin Tekin, Christopher B. O’Brien, Lynn Feun, Rodrigo Vianna and Phillipe Abreu
Cancers 2023, 15(12), 3165; https://doi.org/10.3390/cancers15123165
Available online: https://www.mdpi.com/2072-6694/15/12/3165

“AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation”
by I-Hsuan Chen, Chien-Chin Hsu, Chee-Chien Yong, Yu-Fan Cheng, Chih-Chi Wang, Chih-Che Lin and Chao-Long Chen
Cancers 2023, 15(5), 1551; https://doi.org/10.3390/cancers15051551
Available online: https://www.mdpi.com/2072-6694/15/5/1551

“Declined Organs for Liver Transplantation: A Right Decision or a Missed Opportunity for Patients with Hepatocellular Carcinoma?”
by Vladimir J. Lozanovski, Said Adigozalov, Elias Khajeh, Omid Ghamarnejad, Ehsan Aminizadeh, Christina Schleicher, Thilo Hackert, Beat Peter Müller-Stich, Uta Merle, Susanne Picardi et al.
Cancers 2023, 15(5), 1365; https://doi.org/10.3390/cancers15051365
Available online: https://www.mdpi.com/2072-6694/15/5/1365

“Influence of De Novo Malignancies on Long-Term Survival after Lung Transplantation”
by Eloisa Ruiz, Paula Moreno, Francisco Javier Gonzalez, Alba Maria Fernandez, Benito Cantador, Juan Luis Parraga, Angel Salvatierra and Antonio Alvarez
Cancers 2023, 15(15), 4011; https://doi.org/10.3390/cancers15154011
Available online: https://www.mdpi.com/2072-6694/15/15/4011

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office